Because the findings of this study are limited to surgically resected patients with PDA or IPMN, the temporal relationship between MCP-1 level changes in the serum and the progression of PDA remains unknown. The gene discussed is CCL2; the disease is pancreatic intraductal papillary-mucinous neoplasm.